Journal list Promote Sponsor
verified SJR 1,036 · Q2 • database Scopus / SJR & Web of Science indexed
Current Problems in Cancer
United States · Elsevier Inc.
workspace_premium Q2 — Oncology lock Subscription

Current Problems in Cancer

Current Problems in Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 51. It has an SJR impact factor of 1,036 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1,036.

ISSN: 0147-0272
Publisher: Elsevier Inc.
Category: Oncology
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
1,036 Q2
H-index 51
Acceptance rate pie_chart
32%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,036

H-index

51

Docs (year)

55

Docs 3y

199

Total refs

2921

Cites 3y

479

Citable 3y

188

Cites/Doc 2y

2.37

Ref/Doc

53.11

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Neoadjuvant chemotherapy followed by surgery in lung cancer: Indian scenario

View more

Part II. Medical imaging of ductal carcinoma in situ

View more

Part I. In search of excellence: The American Society of Clinical Oncology's National Initiative on Cancer Care Quality

View more

Part II. Physical therapy

View more

Part V. Adjuvant therapies for ductal carcinoma in situ

View more

Preface

View more

Surgical Reconstruction in Melanoma

View more

The epidermal growth factor receptor: A new target for anticancer therapy

View more

Update on primary HPV screening for cervical cancer prevention

View more

What can a woman do about her risk of dying of breast cancer?

View more

Part IV. Surgery for ductal carcinoma in situ

View more

Part I. Acupuncture

View more
SHOW MORE ARTICLES

Part I. Epidemiology of ductal carcinoma in situ

View more

Multimodality approaches for rectal cancer

View more

Molecular Alternations in Uveal Melanoma

View more

Melanoma and Nevi: Detection and Diagnosis

View more

Issues, both ethical and practical, in the development and conduct of chemoprevention trials

View more

In brief

View more

Immunotherapy in ovarian cancer

View more

Hereditary Melanoma

View more

Foreword

View more

Foreword

View more

Foreword

View more

Foreword

View more

FAQs